REFERENCES:
1. January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for
the management of patients with atrial fibrillation: A report of the
American college of Cardiology/American heart association task force on
practice guidelines and the heart rhythm society. J Am Coll
Cardiol . 2014;64(21):e1-e76. doi:10.1016/j.jacc.2014.03.022
2. Patel NJ, Deshmukh A, Pant S, et al. Contemporary trends of
hospitalization for atrial fibrillation in the united states, 2000
through 2010 implications for healthcare planning. Circulation .
2014;129(23):2371-2379. doi:10.1161/CIRCULATIONAHA.114.008201
3. Mehra N, Kowlgi GN, Deshmukh AJ. Predictors of Outcomes in Patients
with Atrial Fibrillation: What Can Be Used Now and What Hope Is in the
Future. Curr Cardiovasc Risk Rep . 2020;14(9):1-14.
doi:10.1007/s12170-020-00645-5
4. Arora S, Jaswaney R, Jani C, et al. Catheter Ablation for Atrial
Fibrillation in Patients With Concurrent Heart Failure. Am J
Cardiol . 2020;137:45-54. doi:10.1016/J.AMJCARD.2020.09.035
5. Packer DL, Mark DB, Robb RA, et al. Effect of Catheter Ablation vs
Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac
Arrest among Patients with Atrial Fibrillation: The CABANA Randomized
Clinical Trial. In: JAMA - Journal of the American Medical
Association . Vol 321. American Medical Association; 2019:1261-1274.
doi:10.1001/jama.2019.0693
6. Kowlgi GN, Kapa S. Advances in Atrial Fibrillation Ablation: Energy
Sources Here to Stay. Card Electrophysiol Clin .
2020;12(2):167-174. doi:10.1016/j.ccep.2020.02.005
7. Noseworthy PA, Gersh BJ, Kent DM, et al. Atrial fibrillation ablation
in practice: assessing CABANA generalizability. Eur Heart J .
2019;40(16):1257-1264. doi:10.1093/EURHEARTJ/EHZ085
8. Noheria A, Kumar A, Wylie J V., Josephson ME. Catheter ablation vs
antiarrhythmic drug therapy for atrial fibrillation: a systematic
review. Arch Intern Med . 2008;168(6):581-586.
doi:10.1001/ARCHINTE.168.6.581
9. Pappone C, Vicedomini G, Augello G, et al. Radiofrequency catheter
ablation and antiarrhythmic drug therapy: a prospective, randomized,
4-year follow-up trial: the APAF study. Circ Arrhythm
Electrophysiol . 2011;4(6):808-814. doi:10.1161/CIRCEP.111.966408
10. Lau D, Sandhu RK, Andrade JG, Ezekowitz J, So H, Klarenbach S.
Cost-utility of catheter ablation for atrial fibrillation in patients
with heart failure: An economic evaluation. J Am Heart Assoc .
2021;10(14):19599. doi:10.1161/JAHA.120.019599
11. Chew DS, Loring Z, Anand J, et al. Economic Evaluation of Catheter
Ablation of Atrial Fibrillation in Patients with Heart Failure with
Reduced Ejection Fraction. Circ Cardiovasc Qual Outcomes .
Published online 2020:981-990. doi:10.1161/CIRCOUTCOMES.120.007094
12. Kowlgi GN, Gunda S, Padala SK, Koneru JN, Deshmukh AJ, Ellenbogen
KA. Comparison of Frequency of Atrial Fibrillation in Blacks Versus
Whites and the Utilization of Race in a Novel Risk Score. Am J
Cardiol . 2020;135:68-76. doi:10.1016/j.amjcard.2020.08.029